1
Patients were observed for adverse reactions and dropouts at each time point.
2
Patients in peginterferon group had higher, although statistically not significant adverse reactions.
3
A study with telithromycin reported benefit, but adverse reactions limit its use.
4
Oregovomab was well tolerated and did not produce drug-related serious adverse reactions.
5
All of the serious adverse reactions resolved after the medication was discontinued.
6
The adverse reactions that occur during the first medication are more common.
7
During the 3-month follow-up after treatment, no FMT-related adverse reactions were reported.
8
No adverse reactions were observed with the implementation of the novel device.
9
It was true that humans sometimes had adverse reactions to Slipspace travel.
10
It had also received reports of adverse reactions to the products in children.
11
No serious adverse reactions were noted in patients receiving HD- or SD-CAP therapy.
12
Practical guidance is also provided to ensure proper treatment of any adverse reactions.
13
Just few micrograms of Histamine can result in adverse reactions when administered intravenously.
14
GIs were unable to rank serious adverse reactions associated with IFX.
15
And adverse reactions can quickly impact the companies producing the drugs.
16
Goserelin depot was well tolerated with no withdrawal due to possible adverse reactions.
